I worked in cancer research with some really, really smart people. Every single one of them was sincerely hopeful that the drug they were working on would be a total cure. I know it's hard to believe, but pharma companies are composed of real people who have seen patients, friends, and relatives die of cancer or similar diseases. Researchers want so badly to find a cure for the disease they are working on. The existence of vaccines are proof that when pharma companies can cure something, they do it. I have been in conversations where business factors for a drug were discussed and I can tell you the one thing that was never said was, "Hey guys, make sure it's not an actual cure, or we'll need to kill the project".
A commenter on Slashdot gave another good point on why the industry HAS a reason to develop a cure for cancer:
If any "Big Pharma" company invented a cure for cancer tomorrow, you can bet your ass that they'd be all over it in a heartbeat.
Why? Because, then that company would forever be known as the company that cured cancer. Every new product they make would be a pot of gold. Every ad they put out would be "Muhdikard, a new treatment for erectile dysfunction, from Drugco. We cured cancer.". Every drug company on the face of the planet would kill for that kind of marketing, not to mention the money from selling the cancer cure.
Source: http://science.slashdot.org/comments.pl?sid=2375188&cid=...
I recognize that the argument I made earlier is something of an old saw. But you and I both know that businesses on the scale of most pharma companies are not run only by researchers and engineers, and that the explicit reasons for business decisions anywhere often stem from any number of unspoken ones. I don't imagine even the coldest of bean counters ever says "we need to make sure this research doesn't lead to a cure," and I doubt such a black-and-white assessment of a complex R&D process even occurs to them. But incentives are incentives, and humans are masters of rationalization.
I'm heartened to learn that your teams never felt pressure to put business interests ahead of patient interests. I sincerely hope your experience is common.
There is also a practical reason why I can assure you that people are usually swinging for the fences, especially in cancer: most of the time you don't even know if a drug will work, let alone work well. There is no way to predict (with the obvious exception of vaccines which owing to biology are destined to be cures from the beginning) what your drug will really do until it hits the clinic. So there isn't even a mechanism to offer people an incentive to develop a drug someone has to take over and over vs. a cure, especially in cancer. Certainly, there are chronic conditions like diabetes where there is no real "cure" on the horizon because of the biology of the situation. But in the case of cancer, you almost have to try for a total success because you know you're likely to get far, far less than that when you hit the clinic. Because of this problem, one of the bigger issues in pharma is that flawed projects are allowed to linger long after they should have just been scrapped because powerful scientists believed they would work and convinced management to keep funding them despite some of their issues.
"If we had a cure for cancer, do you think we'd be letting our family die of it?"
I worked for 2.5 years in a finance firm which specialized primarily in biotech stocks. (We were on the "sell side", meaning our clients were hedge funds and mutual funds, and our product was research reports advising whether to buy or sell the stock of certain biotech companies.)
Without fail, the biggest catalysts for moving the stock price were study results, and the better the results, the bigger the jump. Every company absolutely wants that blockbuster drug that cures a disease.
With CLL, for instance, as in the article, there are a number of treatments, in 1st line and 2nd line after relapse, 3rd line, and so on. And doctors prescribe this one or that one, depending on context and what side effects you can tolerate, etc. If your drug is a complete cure and you can jump straight to first line and everyone prescribes your treatment, then that's a gold mine.
A recent example is Cougar Biotechnology, whose cancer drug abiraterone was so insanely successful the company's stock price rocketed and then was acquired shortly thereafter by Johnson & Johnson.
Lastly, if you finished reading the article, you'd see this part:
"With results for the three patients published Wednesday simultaneously in the New England Journal of Medicine and Science Translational Medicine, money for further studies -- not just in this one type of leukemia, but in other cancers -- will likely pour in from both the government and drug companies."
The main impediment: free-loading companies could take advantage of the companies funding the research. One solution would be to start a patent pool, making their inventions freely available to all the companies participating in funding the research.
A senator (Bernie Frank maybe, not sure) recently introduced a bill to tax insurance companies and apply the funds for medical research. That'd be another way to fix the freeloader problem, but then you're stuck with the government choosing the research, and it tends to be overly conservative.
http://www.huffingtonpost.com/dean-baker/bernie-sanders-trie...
I think a company would be hard-pressed to have a pill that cures cancer -- letting millions die each year, because the pill costs $100k. I think there's a non-trivial possibility that the gov't would take that drug for its own uses.
Is there precedent for such a thing?
http://www.msnbc.msn.com/id/18490388/ns/health-aids/t/brazil...
Apparently when the negotiations broke down (Brazil wanted the same rate as Thailand but Merck wanted to charge them more), Brazil declared sovereign property rights in the good of it's citizens.
http://www.fool.com/news/2001/bayzf011025.htm
This was for Cipro for Anthrax. Bayer, at the last minute, gave in to some pricing concessions. There's also been talks about it happening during some H1N1 and avian flu scares.
A $100k pill that cures cancer? I'm not saying it would be taken by the gov't, but I think you'd have to seriously consider it.
Today it is the one treatment that is fully covered by the government for everyone. I would imagine something similar would occur here.
Also not advocating there is some conspiracy going on here.
The person paying for the cure, usually and insurance company, wants it to be as cheap as possible.
The person selling the cure is probably not the same between the two treatment scenarios.
The hospital administering the treatments might have a motive, but they aren't involved in the decisions about whether to go ahead with research.
So, if you had a fairly reliable (at achieving remission) injection, and especially one without the terrible side effects, you should be able to charge at least $400k.
Please inform me which pharmaceutical company would not like an $18 billion/year revenue stream.
Opinions differ as to why that is - I personally suspect the grants system that is used for funding science.
Of course, there is no conspiracy here. It's just the human tendency to rationalize when money is involved. Imagine you run a pharmaceutical company: Your products save lives, right? You want to be able to continue saving lives, so you have to stay profitable. And to stay profitable, you have to make good investments. Products that are used in long-term treatments are good investments. One-time cures aren't.